NO903544L - Fremgangsmaate for oppnaaelse av en polypeptid-analog av human-inter-leukin-3. - Google Patents

Fremgangsmaate for oppnaaelse av en polypeptid-analog av human-inter-leukin-3.

Info

Publication number
NO903544L
NO903544L NO90903544A NO903544A NO903544L NO 903544 L NO903544 L NO 903544L NO 90903544 A NO90903544 A NO 90903544A NO 903544 A NO903544 A NO 903544A NO 903544 L NO903544 L NO 903544L
Authority
NO
Norway
Prior art keywords
deletion
human
residues
ala84
cys84
Prior art date
Application number
NO90903544A
Other languages
English (en)
Other versions
NO301481B1 (no
NO903544D0 (no
Inventor
Lambertus Christiaan Dorssers
Robert Willem Van Leen
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26121243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO903544(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of NO903544D0 publication Critical patent/NO903544D0/no
Publication of NO903544L publication Critical patent/NO903544L/no
Publication of NO301481B1 publication Critical patent/NO301481B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO903544A 1989-08-14 1990-08-13 DNA-fragmenter som koder for analoger av human IL-3, ekspresjonsvektor inneholdende DNA'et, vertscelle transformert med ekspresjonsvektoren og fremgangsmåte for fremstilling av et polypeptid analogt med IL-3 NO301481B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89202082 1989-08-14
EP89202331 1989-09-14

Publications (3)

Publication Number Publication Date
NO903544D0 NO903544D0 (no) 1990-08-13
NO903544L true NO903544L (no) 1991-02-15
NO301481B1 NO301481B1 (no) 1997-11-03

Family

ID=26121243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903544A NO301481B1 (no) 1989-08-14 1990-08-13 DNA-fragmenter som koder for analoger av human IL-3, ekspresjonsvektor inneholdende DNA'et, vertscelle transformert med ekspresjonsvektoren og fremgangsmåte for fremstilling av et polypeptid analogt med IL-3

Country Status (17)

Country Link
EP (2) EP0413383B1 (no)
JP (1) JP3192416B2 (no)
AT (1) ATE154638T1 (no)
AU (1) AU636641B2 (no)
CA (1) CA2023246C (no)
DD (1) DD301724A9 (no)
DE (1) DE69030937T2 (no)
DK (1) DK0413383T3 (no)
ES (1) ES2106017T3 (no)
FI (1) FI105192B (no)
GR (1) GR3024679T3 (no)
HU (1) HUT54411A (no)
IE (2) IE902921A1 (no)
IL (1) IL95350A0 (no)
NO (1) NO301481B1 (no)
NZ (1) NZ234869A (no)
PT (1) PT94992B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE179211T1 (de) * 1991-10-07 1999-05-15 Medvet Science Pty Ltd Menschliche il-3-varianten
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
JPH08503706A (ja) * 1992-11-24 1996-04-23 ジー．ディー．サール アンド カンパニー インターロイキン−３（ｉｌ−３）多重変異ポリペプチド
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6361977B1 (en) * 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US6413509B1 (en) 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
NZ269766A (en) * 1993-07-28 1998-01-26 Medvet Science Pty Ltd Haemopoietic growth factor antagonists; relates to modified forms of such factors
US6465616B1 (en) 1994-04-08 2002-10-15 Bresagen Limited Interleukin-5 antagonist
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
US6270758B1 (en) 1998-10-08 2001-08-07 Duke University Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
JP4735670B2 (ja) * 2008-06-11 2011-07-27 富士ゼロックス株式会社 プリント基板および画像処理装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
AU617095B2 (en) 1986-12-16 1991-11-21 Dsm N.V. Molecular cloning and expression of human il-3
EP0790307A1 (en) 1986-12-16 1997-08-20 Gist-Brocades B.V. Molecular cloning and expression of human IL-3
EP0342206A4 (en) * 1987-01-20 1990-09-19 Immunex Corporation Human interleukin-3 proteins
US4743264A (en) * 1987-02-05 1988-05-10 Sherva Parker Carole J External prothesis with magnetic field
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".

Also Published As

Publication number Publication date
FI105192B (fi) 2000-06-30
DE69030937D1 (de) 1997-07-24
PT94992B (pt) 1997-09-30
FI903996A0 (fi) 1990-08-13
JPH0420295A (ja) 1992-01-23
AU636641B2 (en) 1993-05-06
NO301481B1 (no) 1997-11-03
EP0810285A2 (en) 1997-12-03
NZ234869A (en) 1991-12-23
EP0810285A3 (en) 1998-07-08
CA2023246C (en) 2002-02-19
PT94992A (pt) 1991-04-18
NO903544D0 (no) 1990-08-13
DK0413383T3 (da) 1997-07-07
AU6096090A (en) 1991-02-14
JP3192416B2 (ja) 2001-07-30
EP0413383B1 (en) 1997-06-18
HUT54411A (en) 1991-02-28
GR3024679T3 (en) 1997-12-31
IE980055A1 (en) 2000-02-23
DE69030937T2 (de) 1997-10-09
ATE154638T1 (de) 1997-07-15
CA2023246A1 (en) 1991-02-15
EP0413383A1 (en) 1991-02-20
ES2106017T3 (es) 1997-11-01
DD301724A9 (de) 1993-08-12
IE902921A1 (en) 1991-02-27
IL95350A0 (en) 1991-06-30

Similar Documents

Publication Publication Date Title
NO903544D0 (no) Fremgangsmaate for oppnaaelse av en polypeptid-analog av human-inter-leukin-3.
DE3588225T2 (de) Anti-Lymphotoxin-Antikörper, Herstellung und Verwendung
KR890003802A (ko) 재조합 dna 기술에 의해 제조된 소의 췌장 트립신 억제제, 그 제조 방법, 발현 벡터 및 재조합 숙주 및 그의 제약적 용도
RU93045577A (ru) Слитные полипептиды
CN1294596A (zh) 修饰蛋白的免疫原性
DK0672145T3 (da) Interleukin-3-(IL-3)-polypeptider med flere mutationer
GB2246783A (en) Fusion proteins containing n-terminal fragments of human serum albumin
AU7565991A (en) Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
EP0965637A4 (en) Fas ANTIGEN DERIVATIVES
Davis et al. Basic fibroblast growth factor induces 3T3 fibroblasts to synthesize and secrete a cyclophilin-like protein and β2-microglobulin
HUT69169A (en) T-cell-suppressive peptide fragments of human myelin basic protein (hmbp) and pharmaceutical compositions containing them
Bornstein et al. The comparative biochemistry of collagen: The structure of rabbit skin collagen and its relevance to immunochemical studies of collagen
EP0528686B8 (en) Process for producing peptides
Meloun et al. Amino acid sequence of bovine spleen cathepsin B.
Herzbeck et al. Functional and Molecular Characterization of a Monoclonal Antibody against the 165–186 Peptide of Human 1β
NO20011263D0 (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
Gilbert The expression of human prolactin in Escherichia coli.
FI961398L (fi) Menetelmä terapeuttisesti käyttökelpoisen peptidin valmistamiseksi
WO1994025594A3 (en) Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii
MXPA00007746A (en) Modifying protein immunogenicity
KR920701253A (ko) M-csf 유도체, 그 유도체의 발현 벡터, 그 벡터를 갖는 형질 전환체 및 이들의 제조방법